Stay updated with breaking news from Sciences Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fourteen analysts that are covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 1 […]
Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Stock analysts at Leerink Partnrs decreased their FY2025 earnings estimates for Exact Sciences in a research report issued to clients and investors on Wednesday, August 2nd. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will post earnings per share of $0.83 for the […]
Alpha DNA Investment Management LLC acquired a new position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 15,342 shares of the medical research company’s stock, valued at approximately $1,040,000. Other hedge funds and […]
Achmea Investment Management B.V. raised its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3,322.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 10,986 shares of the medical research company’s stock after acquiring an additional 10,665 shares during the […]
Victory Capital Management Inc. lifted its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 537.5% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 126,755 shares of the medical research company’s stock after acquiring an additional 106,872 shares during the period. […]